MedicineNews.net - Medical Updates

Atezolizumab in combination with Bevacizumab has increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma

The phase III IMbrave150 study, evaluating Atezolizumab ( Tecentriq ) in combination with Bevacizumab ( Avastin ) as a treatment for people with unresectable hepatocellular carcinoma ( HCC ) who have ... read article

Mvasi, a biosimilar to the cancer drug Avastin, approved from FDA for certain colorectal, lung, brain, kidney and cervical cancers

The FDA ( Food and Drug Administration ) has approved Mvasi ( Bevacizumab-awwb ) as a biosimilar to Avastin ( Bevacizumab ) for the treatment of multiple types of cancer. Mvasi is the first biosimil ... read article

Nivolumab in glioblastoma multiforme, CheckMate -143 did not meet its primary endpoint of improved overall survival

CheckMate -143, a randomized phase 3 clinical trial evaluating the efficacy and safety of Nivolumab ( Opdivo ) in patients with first recurrence of glioblastoma multiforme ( GBM ), did not meet its pr ... read article

Nivolumab in glioblastoma multiforme, CheckMate -143 did not meet its primary endpoint of improved overall survival

CheckMate -143, a randomized phase 3 clinical trial evaluating the efficacy and safety of Nivolumab ( Opdivo ) in patients with first recurrence of glioblastoma multiforme ( GBM ), did not meet its pr ... read article

Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer

Interim analysis of a large, randomized clinical trial has shown that patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the dr ... read article

Avastin plus chemotherapy for patients with metastatic colorectal cancer: FDA approved

Roche has announced that the FDA ( Food and Drug Administration ) has approved a new use of Avastin ( Bevacizumab ) in combination with fluoropyrimidine-based Irinotecan or Oxaliplatin chemotherapy fo ... read article

Avastin for the treatment of women with recurrent, Platinum-sensitive ovarian cancer: approved in Europe

Roche has announced that the European Commission ( EC ) has approved Avastin ( Bevacizumab ) in combination with standard chemotherapy ( Carboplatin and Gemcitabine ) as a treatment for women with fir ... read article

Anti-angiogenesis treatments: Bevacizumab, Sunitinib increase breast cancer stem cells

Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, suggesting a possible explanation for why these drugs d ... read article

Avastin for the treatment of women with newly diagnosed, advanced ovarian cancer, EU approved

Roche has informed that the European Commission has approved Avastin ( Bevacizumab ) in combination with standard chemotherapy ( Carboplatin and Paclitaxel ) as a front-line treatment for women with a ... read article

Risk of osteonecrosis of the jaw associated with Bevacizumab and Sunitinib

Treatment with Bevacizumab or Sunitinib may be a risk factor for the development of osteonecrosis of the jaw, particularly if a patient has previously received, or is treated concurrently with, bispho ... read article

Avastin added to chemotherapy reduces the risk of disease progression during the first year of treatment in patients with newly diagnosed ovarian carcinoma

Adding Bevacizumab ( Avastin ) to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment. The ICON7 trial included ... read article

Nexavar can reduce the size of tumor prior to surgery in advanced kidney carcinoma

Physicians who conducted a pilot study at University of North Carolina ( UNC ) Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug Sorafenib ( Nexavar ) can reduce t ... read article

Management of renal cell cancer

Renal cell carcinoma ( RCC ) accounts for about 3% of all solid tumours in adults, and worldwide, more than 200.000 new cases and 100.000 deaths result each year from this malignancy. In contrast ... read article

Diabetic macular oedema: antiangiogenic therapy with Bevacizumab

Diabetic macular oedema is a common complication of diabetic retinopathy. The retina at the macula thickens and this can cause gradual loss of central vision. Although grid or focal laser photocoagula ... read article

Bevacizumab improves hearing in some patients with neurofibromatosis type 2

Treatment with the angiogenesis inhibitor Bevacizumab ( Avastin ) improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 ( NF2 ). In a paper, published in the New E ... read article